Leukemia virus long terminal repeat activates NFκB pathway by a TLR3-dependent mechanism

被引:15
作者
Abujamra, AL
Spanjaard, RA
Akinsheye, I
Zhao, XS
Faller, DV
Ghosh, SK
机构
[1] Boston Univ, Sch Med, Canc Res Ctr, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA
[3] Boston Univ, Sch Med, Dept Otolaryngol, Boston, MA 02118 USA
[4] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA
关键词
leukemia virus; LTR; Transactivation; NF kappa B; TLR3;
D O I
10.1016/j.virol.2005.10.003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The long terminal repeat (LTR) region of leukemia viruses plays a critical role in tissue tropism and pathogenic potential of the viruses. We have previously reported that U3-LTR from Moloney murine and feline leukemia viruses (MO-MULV and FeLV) upregulates specific cellular genes in trails in an integration-independent way. The U3-LTR region necessary for this action does not encode a protein but instead makes a specific RNA transcript. Because several Cellular genes transactivated by the U3-LTR call also be activated by NF kappa B, and because the antiapoptotic and growth promoting activities of NF kappa B have been implicated in leukemogenesis, we investigated whether FeLV U3-LTR call activate NF kappa B signaling. Here, we demonstrate that FeLV U3-LTR indeed upregulates the NF kappa B signaling pathway via activation of Ras-Raf-I kappa B kinase (IKK) and degradation of I kappa B. UR-mediated transcriptional activation of genes did not require new protein synthesis suggesting all active role of the LTR transcript in the process. Using Toll-like receptor (TLR) deficient HEK293 cells and PKR-/- mouse embryo fibroblasts, we further demonstrate that although dsRNA-activated protein kinase R (PKR) is not necessary, TLR3 is required for the activation of NF kappa B by the LTR. Our Study thus demonstrates involvement of a TLR3-dependent but PKR-independent dsRNA-mediated signaling pathway for NF kappa B activation and thus provides a new mechanistic explanation of LTR-mediated cellular gene transactivation. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:390 / 403
页数:14
相关论文
共 92 条
[31]  
FRACCHIOLLA NS, 1993, ONCOGENE, V8, P2839
[32]   A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling [J].
Geiss, G ;
Jin, G ;
Guo, JJ ;
Bumgarner, R ;
Katze, MG ;
Sen, GC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (32) :30178-30182
[33]   NF-κB and rel proteins:: Evolutionarily conserved mediators of immune responses [J].
Ghosh, S ;
May, MJ ;
Kopp, EB .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :225-260
[34]   Feline leukemia virus long terminal repeat activates collagenase IV gene expression through AP-1 [J].
Ghosh, SK ;
Faller, DV .
JOURNAL OF VIROLOGY, 1999, 73 (06) :4931-4940
[35]   Long terminal repeat regions from exogenous but not endogenous feline leukemia viruses transactivate cellular gene expression [J].
Ghosh, SK ;
Roy-Burman, P ;
Faller, DV .
JOURNAL OF VIROLOGY, 2000, 74 (20) :9742-9748
[36]   DISTINCT SEGMENTS WITHIN THE ENHANCER REGION COLLABORATE TO SPECIFY THE TYPE OF LEUKEMIA INDUCED BY NONDEFECTIVE FRIEND AND MOLONEY VIRUSES [J].
GOLEMIS, E ;
LI, Y ;
FREDRICKSON, TN ;
HARTLEY, JW ;
HOPKINS, N .
JOURNAL OF VIROLOGY, 1989, 63 (01) :328-337
[37]  
Guttridge DC, 1999, MOL CELL BIOL, V19, P5785
[38]   IKKγ serves as a docking subunit of the IκB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein [J].
Harhaj, EW ;
Sun, SC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (33) :22911-22914
[39]   ACTIVATION OF A CELLULAR ONC GENE BY PROMOTER INSERTION IN ALV-INDUCED LYMPHOID LEUKOSIS [J].
HAYWARD, WS ;
NEEL, BG ;
ASTRIN, SM .
NATURE, 1981, 290 (5806) :475-480
[40]   The toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily [J].
Heil, F ;
Ahmad-Nejad, P ;
Hemmi, H ;
Hochrein, H ;
Ampenberger, F ;
Gellert, T ;
Dietrich, H ;
Lipford, G ;
Takeda, K ;
Akira, S ;
Wagner, H ;
Bauer, S .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (11) :2987-2997